U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H21BrN2O
Molecular Weight 325.244
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BROMADOLINE

SMILES

CN(C)[C@H]1CCCC[C@@H]1NC(=O)C2=CC=C(Br)C=C2

InChI

InChIKey=UFDJFJYMMIZKLG-KBPBESRZSA-N
InChI=1S/C15H21BrN2O/c1-18(2)14-6-4-3-5-13(14)17-15(19)11-7-9-12(16)10-8-11/h7-10,13-14H,3-6H2,1-2H3,(H,17,19)/t13-,14-/m0/s1

HIDE SMILES / InChI

Molecular Formula C15H21BrN2O
Molecular Weight 325.244
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Bromadoline is a selective agonist of a μ-opioid receptor with potent analgesic activity developed by the Upjohn company in the 1970s for pain management.

CNS Activity

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
R8DWN01P1M
Record Status Validated (UNII)
Record Version